The sleep drug market is about to get a whole lot bigger. “The $2.5 billion U.S. insomnia market is expected to get a whole lot bigger starting in the second half of next year . . .
. . . A massive ad campaign – one analysts compare in magnitude to those for Viagra and Lipitor – is expected to follow six months after the initial rollout of Indiplon.”
